The skin microbiome as a clinical biomarker in atopic eczema: Promises, navigation, and pitfalls
Atopic eczema (atopic dermatitis [AD]) is a disease with severe quality-of-life impairment that affects 40% of children and 5% of the adult population.1 The underlying pathomechanisms of AD are predominantly a skin barrier defect together with microbiome dysbiosis and significant immune dysregulation.1,2
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Matthias Reiger, Claudia Traidl-Hoffmann, Avidan U. Neumann Tags: Paradigms and perspectives Source Type: research